The biocompatibility of nanodiamonds and their application in drug delivery systems

Theranostics

Volumn 2, Issue 3, 2012, Pages 302-312

  Zhu, Ying ^a   Li, Jing ^a   Li, Wenxin ^a   Zhang, Yu ^a   Yang, Xiafeng ^a,b   Chen, Nan ^a   Sun, Yanhong ^a   Zhao, Yun ^b   Fan, Chunhai ^a   Huang, Qing ^a  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Adsorption model; Biocompatibility; Drug delivery system; Nanodiamonds (NDs); Versatility

Indexed keywords

CARBON NANOTUBE; DOXORUBICIN; NANODIAMOND; NANOPARTICLE; PHOSPHATE BUFFERED SALINE;

BIOCOMPATIBILITY; BREAST CARCINOMA; CYTOTOXICITY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FLUORESCENCE IMAGING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; POROSITY; REVIEW; SUSTAINED RELEASE FORMULATION;

EID: 84864554880     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3627     Document Type: Review

References (65)

1. Osawa E. Single-nano buckydiamond particles: synthesis strategies, characterization methodologies and emerging applications. In: Ho D, ed. Nanodiamonds-applications in biology and nanoscale medicine. New York: Springer Science+Business Media;2010:1-33.
2. Baidakova M, Vul' A. New prospects and frontiers of nanodiamond clusters. J Phys D: Appl Phys 2007,40:6300-6311.
3. Chang IP, Hwang KC, Chiang CS. Preparation of fluorescent magnetic nanodiamonds and cellular imaging. J Am Chem Soc. 2008;130: 15476-15481.
4. Chang YR, Lee HY, Chen K, et al. Mass production and dynamic imaging of fluorescent nanodiamonds. Nat Nanotechnol. 2008; 3: 284-288.
5. Chao JI, Perevedentseva E, Chung PH, et al. Nanometer-sized diamond particle as a probe for biolabeling. Biophys J. 2007; 93: 2199-2208.
6. Pramatarova L, Dimitrova R, Spassov EPT, et al. Peculiarities of hydroxyapatite/nanodiamond composites as novel implants. J Phys Conf Ser. 2007; 93: 012049.
7. Huang H, Pierstorff E, Osawa E, et al. Active nanodiamond hydrogels for chemotherapeutic Delivery. Nano Lett. 2007;7: 3305-3314.
8. Xing Y, Dai L. Nanodiamonds for nanomedicine. Nanomedicine 2009; 4: 207-218.
9. Li J, Zhu Y, Li WX, et al. Nanodiamonds as intracellular transporters of chemotherapeutic drug. Biomaterials. 2010; 31: 8410-8418.
10. Schrand AM, Huang HJ, Carlson C, et al. Are diamond nano-particles cytotoxic? J Phys Chem B. 2007;111:2-7.
11. Schrand A, Dai L, Schlager J, et al. Differential biocompatibility of carbon nanotubes and nanodiamonds. Diam Relat Mater. 2007;16:2118-2123.
12. Liu K, Cheng C, Chang C, et al. Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology. 2007; 18: 325102.
13. Liu K K, Wang C C, Cheng C L, et al. Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials. 2009; 30: 4249-4259.
14. Xing Y, Xiong W, Zhu L, et al. DNA damage in embryonic stem cells caused by nanodiamonds. ACS Nano. 2011; 5: 2376-2384.
15. Magrez A, Kasas S, Salicio V, et al. Cellular toxicity of car-bon-based nanomaterials. Nano Lett. 2006, 6: 1121-1125.
16. Zhang XY. Biological effects of three kinds of carbon nano-materials; Dissertation for the Doctoral Degree. Shanghai: Shanghai Institute of Applied Physics, CAS. 2010: 61-64.
17. Vaijayanthimala V, Tzeng YK, Chang HC, et al. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology, 2009; 20:425103.
18. Yuan Y, Wang X, Jia G, et al. Pulmonary toxicity and transloca-tion of nanodiamond in mice. Diam Relat Mater. 2010; 19: 291-299.
19. Zhang XY, Yin JL, Kang Cheng, et al. Biodistribution and tox-icity of nanodiamonds in mice after intratracheal instillation. Toxicol Lett. 2010; 198: 237-243.
20. Lam CW, James JT, McCluskey R, et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci, 2004; 77: 126-134.
21. Warheit BD, Laurence BR, Reed KL, et al. Comparative pulmonary toxicity assessment of single wall carbon nanotubes in rats. Toxicol Sci. 2004; 77:117-125.
22. Muller L, Huaux F, Moreau N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 2005; 207: 221-231.
23. Schrand AM, Hens SAC, Shenderova OA. Nanodiamond particles: properties and perspectives for bioapplications. Crit Rev Solid State. 2009; 34: 18-74.
24. Puzyr AP, Baron AV, Purtov KV, et al. Nanodiamonds with novel properties: a biological study. Diamond Relat Mater. 2007; 16: 2124-2128.
25. Bakowicz K, Mitura S. Biocompatibility of NCD. Journal of Wide Bandgap Materials. 2002; 9: 261-272.
26. 60(OH)x and its biodistribution studies. Nucl Med Biol. 2002; 29: 707-710.
27. y. J Radioanal Nucl Ch. 2001; 250: 363-364.
28. Wang HF, Wang J, Deng XY, et al. Biodistribution of carbon single-walled nanotubes in mice. J Nanosci Nanotechnol. 2004; 4: 1019-1024.
29. Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. PNAS. 2006; 28: 3357-3362.
30. Liu Z, Cai WB, He L, et al. In vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nat Nanotechnol. 2007; 2: 47-50.
31. Guo JX, Zhang X, Li QN. Biodistribution of functionalized multi-wall carbon nanotubes in mice. Nucl Med Biol. 2007; 34: 579-583.
32. Yuan Y, Chen YW, Liu JH, et al. Biodistribution and fate of nanodiamonds in vivo. Diamond Relat Mater. 2009;18: 95-100.
33. Rojas S, Gispert JD, Martin R, et al. Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. ACS Nano. 2011; 5: 5552-5559.
34. Jia NQ, Lian Q, Shen HB, et al. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by function-alized multiwalled carbon nanotubes. Nano Lett. 2007; 7: 2976-2980.
35. Liu Z, Sun XM, Nakayama-Ratchford N, et al. Supramolecular chemistry on water-soluble carbon nanotubes for Drug Loading and Delivery. ACS Nano. 2007; 1: 50-56.
36. Zhang LM, Lu ZX, Zhao QH, et al. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small. 2011; 7: 460-464.
37. Huang P, Xu C, Lin J, et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics.2011; 1:240-250.
38. Zhang XK, Meng LJ, Lu QH, et al. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials. 2009; 30: 6041-6047.
39. Manna SK, Sarkar S, Barr J, et al. Single-walled carbon-nanotube induces oxidative stress and activates nuclear transcription factor-κB in human keratinocytes. Nano Lett. 2005; 5: 1676-1684.
40. Zhang YB, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochro-mocytoma-derived PC12 cells. ACS Nano. 2010; 4: 3181-3186.
41. Wang JY, Sun PP, Bao YM, et al. Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol in vitro. 2011; 25: 242-250.
42. Hartl A, Schmich E, Garrido JA, et al. Protein-modified nano-crystalline diamond thin films for biosensor applications. Nat Mater. 2004; 3: 736-742.
43. Liu Y, Khabashesku VN, Halas NJ. Fluorinated nanodiamond as a wet chemistry precursor for diamond coatings covalently bonded to glass surface. J Am Chem Soc. 2005; 127: 3712-3713.
44. Huang HJ, Pierstorff E, Osawa E, et al. Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm. ACS Nano. 2008; 2:203-212.
45. Huang HJ, Dai LM, Wang DH, et al. Large-scale self-assembly of dispersed nanodiamonds. J Mater Chem. 2008; 18: 1347-1352.
46. Lam R, Chen M, Pierstorff E, et al. Nanodiamond-embedded microfilm devices for localized chemotherapeutic elution. ACS Nano. 2008; 2: 2095-2102.
47. Chow EK, Zhang XQ, Chen M, et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med. 2011; 3: 73ra21.
48. Adnan A, Lam R, Chen HN, et al. Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier. Mol Pharmaceutics. 2011; 8: 368-374.
49. Chen M, Pierstorff ED, Lam R, et al. Nanodiamond-mediated delivery of water-insoluble therapeutics. ACS Nano. 2009; 3: 2016-2022.
50. Shimkunas RA, Robinson E, Lam R, et al. Nanodia-mond-insulin complexes as pH-dependent protein delivery vehicles. Biomaterials. 2009; 30: 5720-5728.
51. Ma XW, Zhao YL, Liang XJ. Nanodiamond delivery circum-vents tumor resistance to doxorubicin. Acta Pharmacol Sin. 2011; 32: 543-544.
52. Guan B, Zou F, Zhi JF. Nanodiamond as the pH-responsive vehicle for an anticancer drug. Small. 2010; 6: 1514-1519.
53. Li XX, Shao JQ, Qin Y, et al. TAT-conjugated nanodiamond for the enhanced delivery of doxorubicin. J Mater Chem. 2011; 21: 7966-7973.
54. Liu KK, Zheng WW, Wang CC, et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology. 2010; 21: 315106.
55. Wanga HD, Yang QQ, Niu CH. Functionalization of nanodia-mond particles with N,O-carboxymethyl chitosan. Diam Relat Mater. 2010; 19: 441-444.
56. Purtov KV, Petunin AI, Burov AE, et al. Nanodiamonds as carriers for address delivery of biologically active substances. Nanoscale Res Lett. 2010; 5: 631-636.
57. Vaijayanthimala V, Chang HC. Functionalized fluorescent nanodiamonds for biomedical applications. Nanomedicine. 2009; 4: 47-55.
58. Yu SJ, Kang MW, Chang HC, et al. Bright fluorescent nanodi-amonds: no photobleaching and low cytotoxicity. J Am Chem Soc. 2005; 127: 17604-17605.
59. Fu CC, Lee HY, Chen K, et al. Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proc Natl Acad Sci. 2007; 104: 727-732.
60. Hurt RH, Monthioux M, Kane A. Toxicology of carbon nano-materials: status, trends, and perspectives on the special issue. Carbon. 2006; 44: 1028-1033.
61. Zhu Y, Ran TC, Li YG, et al. Dependence of the cytotoxicity of multi-walled carbon nanotubes on the culture medium. Nano-technology. 2006; 17: 4668-4674.
62. Casey A, Davoren M, Herzog E, et al. Probing the interaction of single walled carbon nanotubes within cell culture medium as a precursor to toxicity testing. Carbon. 2007; 45: 34-40.
63. Casey A, Herzog E, Davoren M, et al. Spectroscopic analysis confirms the interactions between single walled carbon nano-tubes and various dyes commonly used to assess cytotoxicity. Carbon. 2007; 45: 1425-1432.
64. Zhu Y, Li WX, Li QN, et al. Effects of serum proteins on intra-cellular uptake and cytotoxicity of carbon nanoparticles. Carbon. 2009; 47: 1351-1358.
65. Hu W B, Peng C, Lv M, et al. Protein corona-mediated mitigation of cytotoxicity of grapheme oxide. ACS Nano. 2011; 5: 3693-3700.